The Drug Enforcement Administration (DEA) told House lawmakers that the agency is “now conducting its review” of marijuana as a Schedule 1 drug, according to a letter obtained by Punchbowl News.
What Happened: The fate of marijuana's federal classification hangs in the balance as the DEA asserts its "final authority" on rescheduling, regardless of an August letter recommending that it reclassify cannabis from a Schedule I to a Schedule III substance.
Once the HHS made its recommendation, according to the letter, which was sent last month, “DEA conducts its own review,” reported Punchbowl.
“DEA has the final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act, after considering the relevant statutory and regulatory criteria and HHS’s ...